← Unusual insider activity · Company hub
ELV Elevance Health, Inc.
Insider figures are trailing 90 days, open-market Form 4 only. Institutional figures are the latest reported quarter. These windows are not simultaneous.
-$4.7M net selling - trailing 90 days
0 buyers - 1 unique sellers
Historical context: most recent complete month (2026-10) is the 2nd percentile of this ticker's monthly net P/S flow over 25 complete months. Lower percentiles are more selling; higher are more buying. P10–P90: -$1.8M to $225K.
Institutional activity: not available - insufficient comparable institutions for the latest complete quarter.
open-market Form 4 only - grants, exercises, tax withholding excluded. ~ derived from SEC-reported shares x price.
Institutional activity: not available - insufficient comparable institutions for the latest complete quarter.
Who is responsible
| Insider | Role | Net activity | Rows |
|---|---|---|---|
| Kaye Mark | EVP & CFO | -~$4.7M | 13 |
Transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| October 22, 2026 | Kaye Mark | EVP & CFO | 13 reported sale rows | 10584 | — | ~$4.7M |
| October 22, 2026 | Kaye Mark | EVP & CFO | S | -240 | 438.22 | ~$0.1M |
| October 22, 2026 | Kaye Mark | EVP & CFO | S | -273 | 447.19 | ~$0.1M |
| October 22, 2026 | Kaye Mark | EVP & CFO | S | -827 | 446.05 | ~$0.4M |
| October 22, 2026 | Kaye Mark | EVP & CFO | S | -1720 | 440.44 | ~$0.8M |
| October 22, 2026 | Kaye Mark | EVP & CFO | S | -400 | 434 | ~$0.2M |
| October 22, 2026 | Kaye Mark | EVP & CFO | S | -321 | 435.25 | ~$0.1M |
| October 22, 2026 | Kaye Mark | EVP & CFO | S | -1660 | 436.2 | ~$0.7M |
| October 22, 2026 | Kaye Mark | EVP & CFO | S | -560 | 437.07 | ~$0.2M |
| October 22, 2026 | Kaye Mark | EVP & CFO | S | -1160 | 439.25 | ~$0.5M |
| October 22, 2026 | Kaye Mark | EVP & CFO | S | -160 | 444.85 | ~$71K |
| October 22, 2026 | Kaye Mark | EVP & CFO | S | -440 | 443.81 | ~$0.2M |
| October 22, 2026 | Kaye Mark | EVP & CFO | S | -480 | 442.61 | ~$0.2M |
| October 22, 2026 | Kaye Mark | EVP & CFO | S | -2343 | 441.34 | ~$1.0M |
| July 17, 2026 | PERU RAMIRO G | — | P | 1000 | 366.05 | ~$0.4M |
| July 17, 2026 | BOUDREAUX GAIL | President and CEO | 2 reported purchase rows | 2725 | — | ~$1.0M |
| July 17, 2026 | BOUDREAUX GAIL | President and CEO | P | 680 | 366.41 | ~$0.2M |
| July 17, 2026 | BOUDREAUX GAIL | President and CEO | P | 2045 | 368.25 | ~$0.8M |
| June 12, 2026 | Penczek Ronald W | CAO & Controller | S | -369 | 403.16 | ~$0.1M |
| June 11, 2026 | Dixon Robert L JR | — | S | -151 | 401.77 | ~$61K |
| May 19, 2026 | Penczek Ronald W | CAO & Controller | S | -1531 | 403.13 | ~$0.6M |
| March 12, 2026 | SCHULMAN AMY W | — | S | -26 | 287.5 | ~$7K |
| March 6, 2026 | Kendrick Charles Morgan JR | EVP & President, Commercial | S | -3196 | 284.92 | ~$0.9M |
| March 5, 2026 | COLLIS STEVEN H | — | P | 3000 | 289.84 | ~$0.9M |
| August 19, 2025 | DeVore Susan D. | — | P | 1200 | 312.15 | ~$0.4M |
| July 18, 2025 | BOUDREAUX GAIL | President and CEO | 3 reported purchase rows | 8500 | — | ~$2.4M |
| July 18, 2025 | BOUDREAUX GAIL | President and CEO | P | 2334 | 286.07 | ~$0.7M |
| July 18, 2025 | BOUDREAUX GAIL | President and CEO | P | 1050 | 287.96 | ~$0.3M |
| July 18, 2025 | BOUDREAUX GAIL | President and CEO | P | 5116 | 287.12 | ~$1.5M |
| April 24, 2025 | Kaye Mark | EVP & CFO | S | -4588 | 424.82 | ~$1.9M |
| March 10, 2025 | Penczek Ronald W | CAO & Controller | S | -443 | 415.13 | ~$0.2M |
| March 5, 2025 | Kendrick Charles Morgan JR | EVP & President, Commercial | S | -3504 | 396.3 | ~$1.4M |
| October 18, 2024 | Kendrick Charles Morgan JR | EVP & President, Commercial | S | -7417 | 432.14 | ~$3.2M |